Connect Biopharma Holdings Ltd
NASDAQ:CNTB

Watchlist Manager
Connect Biopharma Holdings Ltd Logo
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Watchlist
Price: 2.82 USD 4.44% Market Closed
Market Cap: 157.6m USD

Wall Street
Price Targets

CNTB Price Targets Summary
Connect Biopharma Holdings Ltd

Wall Street analysts forecast CNTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTB is 8.06 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
115% Upside
Average
Price Target
8.06 USD
186% Upside
Highest
Price Target
10.5 USD
272% Upside
Connect Biopharma Holdings Ltd Competitors:
Price Targets
NVAX
Novavax Inc
94% Upside
2256
Abbisko Cayman Ltd
84% Upside
AMRN
Amarin Corporation PLC
12% Downside
MDGL
Madrigal Pharmaceuticals Inc
5% Upside
IVVD
Invivyd Inc
203% Upside
2142
Hbm Holdings Ltd
12% Upside
PGEN
Precigen Inc
107% Upside
GILD
Gilead Sciences Inc
10% Upside

Revenue
Forecast

Revenue Estimate
Connect Biopharma Holdings Ltd

The compound annual growth rate of Connect Biopharma Holdings Ltd's revenue for the next 4 years is -2%.

N/A
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Connect Biopharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

Net Income
Forecast

Net Income Estimate
Connect Biopharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CNTB's stock price target?
Price Target
8.06 USD

According to Wall Street analysts, the average 1-year price target for CNTB is 8.06 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

What is Connect Biopharma Holdings Ltd's Revenue forecast?
Projected CAGR
-2%

The compound annual growth rate of Connect Biopharma Holdings Ltd's revenue for the next 4 years is -2%.

Back to Top